GOLPH3 overexpression is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through upregulating MMP-2 and MMP-9

Cellular Physiology and Biochemistry

Volumn 35, Issue 3, 2015, Pages 969-982

  Wang, Ran ^a   Ke, Zun Fu ^a   Wang, Fen ^a   Zhang, Wen Hui ^a   Wang, Yue Feng ^a   Li, Shu Hua ^a   Wang, Lian Tang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

GOLPH3; Metastasis; MMP 2; MMP 9; NSCLC; Prognosis

Indexed keywords

CELL PROTEIN; GELATINASE A; GELATINASE B; GOLGI PHOSPHOPROTEIN 3 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; GOLPH3 PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR MARKER;

ARTICLE; CANCER PROGNOSIS; CELL CULTURE; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG FIBROBLAST; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; WORLD HEALTH ORGANIZATION; ZYMOGRAPHY; AGED; BIOSYNTHESIS; CANCER STAGING; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

AGED; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 84923091667     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000369753     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Bunn PA Jr, Thatcher N: Systemic treatment for advanced (stage iiib/iv) non-small cell lung cancer: More treatment options; more things to consider. Introduction. Oncologist 2008;13:S1-4.
3. Sun S, Ke Z, Wang F, Li S, Chen W, Han A, Wang Z, Shi H, Wang LT, Chen X: Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression. Hum Pathol 2012;43:1051-1060.
4. Wu CC, Taylor RS, Lane DR, Ladinsky MS, Weisz JA, Howell KE: Gmx33: A novel family of trans-golgi proteins identified by proteomics. Traffic 2000;1:963-975.
5. Bell AW, Ward MA, Blackstock WP, Freeman HN, Choudhary JS, Lewis AP, Chotai D, Fazel A, Gushue JN, Paiement J, Palcy S, Chevet E, Lafreniere-Roula M, Solari R, Thomas DY, Rowley A, Bergeron JJ: Proteomics characterization of abundant golgi membrane proteins. J Biol Chem 2001;276:5152-5165.
6. Scott KL, Kabbarah O, Liang MC, Ivanova E, Anagnostou V, Wu J, Dhakal S, Wu M, Chen S, Feinberg T, Huang J, Saci A, Widlund HR, Fisher DE, Xiao Y, Rimm DL, Protopopov A, Wong KK, Chin L: Golph3 modulates mtor signalling and rapamycin sensitivity in cancer. Nature 2009;459:1085-1090.
7. Hua X, Yu L, Pan W, Huang X, Liao Z, Xian Q, Fang L, Shen H: Increased expression of golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer. Diagn Pathol 2012;7:127.
8. Zeng Z, Lin H, Zhao X, Liu G, Wang X, Xu R, Chen K, Li J, Song L: Overexpression of golph3 promotes proliferation and tumorigenicity in breast cancer via suppression of the foxo1 transcription factor. Clin Cancer Res 2012;18:4059-4069.
9. Kunigou O, Nagao H, Kawabata N, Ishidou Y, Nagano S, Maeda S, Komiya S, Setoguchi T: Role of golph3 and golph3l in the proliferation of human rhabdomyosarcoma. Oncol Rep 2011;26:1337-1342.
10. Li XY, Liu W, Chen SF, Zhang LQ, Li XG, Wang LX: Expression of the golgi phosphoprotein-3 gene in human gliomas: A pilot study. J Neurooncol 2011;105:159-163.
11. Zhou X, Zhan W, Bian W, Hua L, Shi Q, Xie S, Yang D, Li Y, Zhang X, Liu G, Yu R: Golph3 regulates the migration and invasion of glioma cells though rhoa. Biochem Biophys Res Commun 2013;433:338-344.
12. Zhang Y, Ma M, Han B: Golph3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: An immunohistochemical analysis. Tumour Biol 2014
13. Lu M, Tian Y, Yue WM, Li L, Li SH, Qi L, Hu WS, Gao C, Si LB, Tian H: Golph3, a good prognostic indicator in early-stage nsclc related to tumor angiogenesis. Asian Pac J Cancer Prev 2014;15:5793-5798.
14. Schmitz KR, Liu J, Li S, Setty TG, Wood CS, Burd CG, Ferguson KM: Golgi localization of glycosyltransferases requires a vps74p oligomer. Dev Cell 2008;14:523-534.
15. Takahashi M, Tsuda T, Ikeda Y, Honke K, Taniguchi N: Role of n-glycans in growth factor signaling. Glycoconj J 2004;20:207-212.
16. Ohtsubo K, Marth JD: Glycosylation in cellular mechanisms of health and disease. Cell 2006;126:855-867.
17. Seeliger H, Guba M, Kleespies A, Jauch KW, Bruns CJ: Role of mtor in solid tumor systems: A therapeutical target against primary tumor growth, metastases, and angiogenesis. Cancer Metastasis Rev 2007;26:611-621.
18. de Visser KE, Eichten A, Coussens LM: Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6:24-37.
19. Grivennikov SI, Greten FR, Karin M: Immunity, inflammation, and cancer. Cell 2010;140:883-899.
20. Nagase H, Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494.
21. Valastyan S, Weinberg RA: Tumor metastasis: Molecular insights and evolving paradigms. Cell 2011;147:275-292.
22. Christofori G: New signals from the invasive front. Nature 2006;441:444-450.
23. Liu L, Wu J, Ying Z, Chen B, Han A, Liang Y, Song L, Yuan J, Li J, Li M: Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res 2012;70:3750-3759.
24. Suzuki M, Iwasaki M, Sugio A, Hishiya A, Tanaka R, Endo T, Takayama S, Saito T: Bag3 (bcl2-associated athanogene 3) interacts with mmp-2 to positively regulate invasion by ovarian carcinoma cells. Cancer Lett 2011;303:65-71.
25. Laplante M, Sabatini DM: Mtor signaling in growth control and disease. Cell 2012;149:274-293.